Low-Dose Radiotherapy for Alzheimer's Disease
NCT07693140
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
To evaluate the safety and tolerability of low-dose whole brain radiotherapy (WBRT) delivered as an induction course of 0.3 Gy × 10 fractions (3.0 Gy total) followed by 12 months of monthly maintenance LDRT (0.3 Gy × 10 fractions; 3.0 Gy total) in patients with Alzheimer's disease or dementia with inflammatory components
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Alzheimer Dementia
- Dementia
- Alzheimer Dementia (AD)
- Alzheimer
- Alzheimer s Disease
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1/2
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Evan Thomas
- Last updated on ClinicalTrials.gov
- July 9, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Renaissance Institute of Precision Oncology & Radiosurgery · Winter Park, FL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.